Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Acquisitions (2021 - 2024)

Veracyte (VCYT) has disclosed Acquisitions for 3 consecutive years, with -$5.0 million as the latest value for Q1 2024.

  • Quarterly Acquisitions changed N/A to -$5.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$5.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$5.0 million for FY2024, N/A changed from the prior year.
  • Acquisitions hit -$5.0 million in Q1 2024 for Veracyte, down from $574.4 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $574.4 million in Q1 2021 to a low of -$5.0 million in Q1 2024.